Correction to “Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.